Back

dr. J.J.W. (Jonas) Kuiper

dr. J.J.W. (Jonas) Kuiper

Associate Professor
dr. J.J.W. (Jonas) Kuiper

Research Programs

Infection & Immunity

Research Output (55)

CRB1-Associated Retinal Dystrophy Patients Have Expanded Lewis Glycoantigen-Positive T Cells

Moekotte Lude, Kuiper Jonas J.W., Hiddingh Sanne, Nguyen Xuan Thanh An, Boon Camiel J.F., van den Born L. Ingeborgh, de Boer Joke H., van Genderen Maria M. 3 Oct 2023, In: Investigative Ophthalmology and Visual Science. 64

Association of Risk Variants in the CFH Gene With Elevated Levels of Coagulation and Complement Factors in Idiopathic Multifocal Choroiditis

de Groot Evianne L., Ossewaarde-van Norel Jeannette, de Boer Joke H., Hiddingh Sanne, Bakker Bjorn, van Huet Ramon A.C., Ten Dam-van Loon Ninette H., Thiadens Alberta A.H.J., Meester-Smoor Magda A., de Jong-Hesse Yvonne, Los Leonoor I., den Hollander Anneke I., Boon Camiel J.F., Kiemeney Lambertus A., van Eijk Kristel R., Bakker Mark K., Hoyng Carel B., Kuiper Jonas J.W. 17 Aug 2023, In: JAMA ophthalmology. 141 , p. 737-745 9 p.

Transcriptome network analysis implicates CX3CR1-positive type 3 dendritic cells in non-infectious uveitis

Hiddingh S., Pandit A., Verhagen F. H., Rijken R., Servaas N. H., Wichers C. G.K., Ten Dam-Van Loon N. H., Imhof S. M., Radstake T. R.D.J., de Boer J. H., Kuiper J. J.W. 12 Apr 2023, In: eLife. 12

Some practical issues about HLA-A29 in birdshot retinochoroiditis

Papasavvas Ioannis, Kuiper Jonas J W, Herbort Carl P 9 Mar 2023, In: Journal of ophthalmic inflammation and infection. 13 , p. 1-3 3 p.

Uncovering the genomic toll of the Black Death

Kuiper Jonas, van Endert Peter Feb 2023, In: Trends in immunology. 44 , p. 90-92 3 p.

Retina-arrestin specific CD8+ T cells are not implicated in HLA-A29-positive birdshot chorioretinitis

Venema W. J., Hiddingh S., Janssen G. M.C., Ossewaarde-van Norel J., van Loon N. Dam, de Boer J. H., van Veelen P. A., Kuiper J. J.W. Feb 2023, In: Clinical Immunology. 247 , p. 1-10 10 p.

Evolutionary immuno-genetics of endoplasmic reticulum aminopeptidase II (ERAP2)

Raja Aroosha, Kuiper Jonas J W 2023, In: Genes and Immunity. 24 , p. 295-302 8 p.

EULAR study group on 'MHC-I-opathy':identifying disease-overarching mechanisms across disciplines and borders

Kuiper Jonas J.W., Prinz Jörg C., Stratikos Efstratios, Kuśnierczyk Piotr, Arakawa Akiko, Springer Sebastian, Mintoff Dillon, Padjen Ivan, Shumnalieva Russka, Vural Seçil, Kötter Ina, Van De Sande Marleen G., Boyvat Ayşe, De Boer Joke H., Bertsias George, De Vries Niek, Krieckaert Charlotte L.M., Leal Inês, Vidovič Valentinčič Nataša, Tugal-Tutkun Ilknur, El Khaldi Ahanach Hanane, Costantino Félicie, Glatigny Simon, Mrazovac Zimak Danijela, Lötscher Fabian, Kerstens Floor G., Bakula Marija, Viera Sousa Elsa, Böhm Peter, Bosman Kees, Kenna Tony J., Powis Simon J., Breban Maxime, Gul Ahmet, Bowes John, Lories Rik J.U., Nowatzky Johannes, Wolbink Gerrit Jan, McGonagle Dennis G., Turkstra Franktien, 2023, In: Annals of the rheumatic diseases. 82 , p. 887-896 10 p.

A Network of Serum Proteins Predict the Need for Systemic Immunomodulatory Therapy at Diagnosis in Noninfectious Uveitis

Kuiper Jonas J W, Verhagen Fleurieke H, Hiddingh Sanne, Wennink Roos A W, Hansen Anna M, Casey Kerry A, Hoefer Imo E, Haitjema Saskia, Drylewicz Julia, Yakin Mehmet, Sen H Nida, Radstake Timothy R D J, de Boer Joke H Sep 2022, In: Ophthalmology science. 2 , p. 1-9

A Blood Protein Signature Stratifies Clinical Response to csDMARD Therapy in Pediatric Uveitis

Wennink Roos A.W., Ayuso Viera Kalinina, Tao Weiyang, Delemarre Eveline M., de Boer Joke H., Kuiper Jonas J.W. 1 Feb 2022, In: Translational Vision Science and Technology. 11

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Contact

Afspraken

Praktisch

hetwkz.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not